Sympagesic 500 mg/ml - 4 mg/ml inj. sol. i.v./i.m. vial

Land: België

Taal: Engels

Bron: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Werkstoffen:

Butylhyoscine Bromide 4 mg/ml - Eq. Hyoscine 2,76 mg/ml; Metamizole Sodium Monohydrate 500 mg/ml - Eq. Noramidopyrine 443 mg/ml

Beschikbaar vanaf:

Dechra Regulatory B.V.

ATC-code:

QA03DB04

INN (Algemene Internationale Benaming):

Metamizole Sodium Monohydrate; Butylhyoscine Bromide

Dosering:

500 mg/ml - 4 mg/ml

farmaceutische vorm:

Solution for injection

Samenstelling:

Metamizole Sodium Monohydrate 500 mg/ml; Butylhyoscine Bromide 4 mg/ml

Toedieningsweg:

Intramuscular use; Intravenous use

Therapeutische categorie:

horse; dog; pig; cattle

Therapeutisch gebied:

Butylscopolamine and Analgesics

Product samenvatting:

CTI code: 550871-02 - Pack size: 5 x 100 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 550871-01 - Pack size: 100 ml - Commercialisation status: YES - CNK code: 4248183 - Delivery mode: Medical prescription

Autorisatie-status:

Commercialised: Yes

Autorisatie datum:

2019-11-29